Unknown

Dataset Information

0

Neglected conditions: Oculopharyngeal muscular dystrophy.

ABSTRACT:

SUBMITTER: Belliveau MJ 

PROVIDER: S-EPMC3971037 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Neglected conditions: Oculopharyngeal muscular dystrophy.

Belliveau Michel J MJ   ten Hove Martin W MW  

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20140401 6

Similar Datasets

Unknown PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
| S-EPMC5380963 | biostudies-literature
Unknown Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy.
| S-EPMC5878694 | biostudies-literature
Unknown Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy.
| S-EPMC7503697 | biostudies-literature
Unknown Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
| S-EPMC5215498 | biostudies-literature
Unknown Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy.
| S-EPMC9804746 | biostudies-literature
Unknown RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement.
| S-EPMC6403420 | biostudies-literature
Unknown PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.
| S-EPMC10840355 | biostudies-literature
Unknown Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.
| S-EPMC5272966 | biostudies-literature
Unknown Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
| S-EPMC6818462 | biostudies-literature
Unknown Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy.
| S-EPMC9050844 | biostudies-literature